CLARIS MULLS OPTIONS FOR SHAREHOLDERS

New Delhi: Drug firm Claris Lifesciences on Thursday said it is considering options such as dividend or share buyback to distribute around `2,077 crore to its shareholders. In a regulatory filing, Claris Lifesciences said that total cash available with the company is `3,614 crore. The company’s board on Thursday approved various expenses and costs aggregating to `1,537 crore relating to various transactions it had undertaken, it added. After adjusting the expenses and costs the net cash that will be available to the company is estimated to be `2,077 crore, Claris Lifesciences said. This translates to cash available per share of around `381 without considering any taxes on the proposed distribution to the shareholders, it added. Shares of Claris Lifesciences on Thursday closed at `335.70 on the BSE.